Aehr Test Systems (NASDAQ:AEHR) Shares Gap Down on Insider Selling

Aehr Test Systems (NASDAQ:AEHR)’s stock price gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $129.23, but opened at $123.01. Aehr Test Systems shares last traded at $120.5230, with a volume of 859,938 shares changing hands.

Specifically, Director Laura Oliphant sold 1,717 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total value of $228,361.00. Following the sale, the director directly owned 16,100 shares in the company, valued at $2,141,300. This trade represents a 9.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Adil Engineer sold 15,000 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $131.02, for a total transaction of $1,965,300.00. Following the sale, the chief operating officer owned 46,977 shares in the company, valued at $6,154,926.54. This trade represents a 24.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In other news, Director Rhea J. Posedel sold 8,413 shares of the business’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $130.00, for a total value of $1,093,690.00. Following the sale, the director owned 387,962 shares of the company’s stock, valued at approximately $50,435,060. The trade was a 2.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Wall Street Analyst Weigh In

A number of research firms recently commented on AEHR. Wall Street Zen upgraded shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. Zacks Research raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Jefferies Financial Group assumed coverage on Aehr Test Systems in a report on Thursday. They set a “buy” rating and a $175.00 price objective on the stock. Lake Street Capital reaffirmed a “buy” rating and set a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Freedom Capital raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 16th. Two analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Aehr Test Systems has a consensus rating of “Buy” and a consensus target price of $136.67.

Aehr Test Systems News Roundup

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Aehr Test Systems Price Performance

The stock has a fifty day moving average price of $92.83 and a 200-day moving average price of $71.45. The company has a market cap of $4.37 billion, a PE ratio of -558.56 and a beta of 3.10.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AEHR. Advocate Investing Services LLC acquired a new position in Aehr Test Systems during the second quarter valued at $26,000. Compagnie Lombard Odier SCmA acquired a new stake in Aehr Test Systems during the 2nd quarter worth about $34,000. Millennium Management LLC boosted its position in Aehr Test Systems by 0.8% during the 4th quarter. Millennium Management LLC now owns 59,219 shares of the semiconductor company’s stock worth $1,196,000 after acquiring an additional 492 shares during the period. KBC Group NV purchased a new position in Aehr Test Systems during the 1st quarter valued at about $30,000. Finally, CoreCap Advisors LLC grew its stake in Aehr Test Systems by 241.8% during the 2nd quarter. CoreCap Advisors LLC now owns 1,251 shares of the semiconductor company’s stock valued at $120,000 after acquiring an additional 885 shares in the last quarter. 69.69% of the stock is owned by institutional investors and hedge funds.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.